Literature DB >> 3084636

Dual fluorochrome analysis of human B lymphocytes: phenotypic examination of resting, anti-immunoglobulin stimulated, and in vivo activated B cells.

K C Anderson, J A Roach, J F Daley, S F Schlossman, L M Nadler.   

Abstract

B cell-enriched preparations were prepared from human peripheral blood and lymphoid tissues by the depletion of T cells and monocytes. Only B cells by virtue of their staining with anti-B1 conjugated to fluorescein were additionally examined. Dual fluorescence staining and flow cytometric analysis demonstrated that the majority of "resting" human peripheral blood and splenic B cells co-express the B cell-restricted B1 and B2 antigens and lack B5, a B cell-restricted activation antigen, and interleukin 2 receptor (IL 2R). In contrast, nearly 2/3 and 1/3 of B1+ cells isolated from lymph node expressed IL 2R and B5 antigens, respectively. When B1+ B cells from peripheral blood and spleen were "activated" by anti-Ig, they lost the B2 antigen and acquired the B5 and/or IL 2R antigens. 2/3 of B1+ cells strongly expressed IL 2R, and up to 1/2 of B1+ cells co-expressed B5. Delineation of increased numbers of B1+ cells that co-express B5 and/or IL 2R within lymphoid tissues obtained from patients with diseases characterized by "activated" B cells provides in vivo confirmation that these phenotypic changes correlate with B cell activation. We believe that the identification and isolation of these and similar subsets of cells defined by differing cell surface phenotypes should further our understanding both of normal B cell activation and the pathophysiology of B cell disease states.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084636

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Immunoglobulin G subclasses secreted by human B cells in vitro in response to interleukin-2 and polyclonal activators.

Authors:  J E Calvert; R Johnstone; M F Duggan-Keen; P Bird
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

2.  Murine complement receptor gene expression: Cr2 gene transcripts are depressed during a high dose microbial challenge.

Authors:  S S Tan; E M O'Toole; C B Kurtz; J H Weis
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

3.  Prognostic factors for ARDS: clinical, physiological and atypical immunodeficiency.

Authors:  Min Song; Yijie Liu; Zhiwen Lu; Hong Luo; Hong Peng; Ping Chen
Journal:  BMC Pulm Med       Date:  2020-04-23       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.